Basal & Squamous Cell Skin Cancers in Adults

We established one of the first treatment programs in the New York City area for basal and squamous cell cancers, also called nonmelanoma skin cancers. Our dermatologists’ expertise in identifying and removing precancerous growths helps prevent many of these skin cancers from developing. When cancer is diagnosed, our medical oncologists, surgical oncologists, and radiation oncologists work together to provide the most effective treatment. Our reconstructive surgeons and rehabilitation doctors may also play an important role in your care.

Clinical Trials and Research Studies

Phase 5

Phase 1/2 Open-Label Rolling-Arm Umbrella Platform Design of Investigational Agents With or Without Pembrolizumab or Pembrolizumab Alone in Participants with Melanoma (KEYNOTE-U02): Substudy 02C

Learn More

Phase 2

A Phase 2 Open-label Multicenter Cohort Study of ALKS 4230 Monotherapy Administered Subcutaneously in Patients With Advanced Cutaneous Melanoma or Intravenously in Patients With Advanced Mucosal Melanoma Who Have Previously Received Anti-PD-[L]1 Therapy - ARTISTRY-6

Learn More

Phase 1

A Phase 1 Multiple-Dose Study to Evaluate the Safety and Tolerability of XmAb 22841 Monotherapy and in Combination with Pembrolizumab in Subjects with Selected Advanced Solid Tumors (DUET-4)

Learn More

Phase 5

A Phase 1/2 Open-Label Rolling-Arm Umbrella Platform Design of lnvestigational Agents With or Without Pembrolizumab or Pembrolizumab Alone in Participants with Melanoma (KEYNOTE-U02): Substudy 02B Ph 1/2 Substudy of 1L Oncological Treatment(s) in Advanced MEL

Learn More